Legos JJ - Search Results

1

Quantitative changes in interleukin proteins following focal stroke in the rat.

Legos JJ, Whitmore RG, Erhardt JA, Parsons AA, Tuma RF, Barone FC. Legos JJ, et al. Neurosci Lett. 2000 Mar 24;282(3):189-92. doi: 10.1016/s0304-3940(00)00907-1. Neurosci Lett. 2000. PMID: 10717423

2

Programmable microchip monitoring of post-stroke pyrexia: effects of aspirin and paracetamol on temperature and infarct size in the rat.

Legos JJ, Mangoni AA, Read SJ, Campbell CA, Irving EA, Roberts J, Barone FC, Parsons AA. Legos JJ, et al. J Neurosci Methods. 2002 Jan 30;113(2):159-66. doi: 10.1016/s0165-0270(01)00488-5. J Neurosci Methods. 2002. PMID: 11772437

3

SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia.

Barone FC, Irving EA, Ray AM, Lee JC, Kassis S, Kumar S, Badger AM, White RF, McVey MJ, Legos JJ, Erhardt JA, Nelson AH, Ohlstein EH, Hunter AJ, Ward K, Smith BR, Adams JL, Parsons AA. Barone FC, et al. Among authors: legos jj. J Pharmacol Exp Ther. 2001 Feb;296(2):312-21. J Pharmacol Exp Ther. 2001. PMID: 11160612

4

SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia.

Legos JJ, Erhardt JA, White RF, Lenhard SC, Chandra S, Parsons AA, Tuma RF, Barone FC. Legos JJ, et al. Brain Res. 2001 Feb 16;892(1):70-7. doi: 10.1016/s0006-8993(00)03228-5. Brain Res. 2001. PMID: 11172750

5

Update on pharmacological strategies for stroke: prevention, acute intervention and regeneration.

Legos JJ, Barone FC. Legos JJ, et al. Curr Opin Investig Drugs. 2003 Jul;4(7):847-58. Curr Opin Investig Drugs. 2003. PMID: 14619407 Review.

6

Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia.

Barone FC, Irving EA, Ray AM, Lee JC, Kassis S, Kumar S, Badger AM, Legos JJ, Erhardt JA, Ohlstein EH, Hunter AJ, Harrison DC, Philpott K, Smith BR, Adams JL, Parsons AA. Barone FC, et al. Among authors: legos jj. Med Res Rev. 2001 Mar;21(2):129-45. doi: 10.1002/1098-1128(200103)21:2<129::aid-med1003>3.0.co;2-h. Med Res Rev. 2001. PMID: 11223862 Review.

7

Caspase inhibitors as neuroprotective agents.

Legos JJ, Lee D, Erhardt JA. Legos JJ, et al. Expert Opin Emerg Drugs. 2001 Apr;6(1):81-94. doi: 10.1517/14728214.6.1.81. Expert Opin Emerg Drugs. 2001. PMID: 15989498

8

Pharmacological interventions for stroke: failures and future.

Legos JJ, Tuma RF, Barone FC. Legos JJ, et al. Expert Opin Investig Drugs. 2002 May;11(5):603-14. doi: 10.1517/13543784.11.5.603. Expert Opin Investig Drugs. 2002. PMID: 11996643 Review.

9

The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injury.

Legos JJ, McLaughlin B, Skaper SD, Strijbos PJ, Parsons AA, Aizenman E, Herin GA, Barone FC, Erhardt JA. Legos JJ, et al. Eur J Pharmacol. 2002 Jun 28;447(1):37-42. doi: 10.1016/s0014-2999(02)01890-3. Eur J Pharmacol. 2002. PMID: 12106800

10

Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist.

Sarau HM, Griswold DE, Bush B, Potts W, Sandhu P, Lundberg D, Foley JJ, Schmidt DB, Webb EF, Martin LD, Legos JJ, Whitmore RG, Barone FC, Medhurst AD, Luttmann MA, Giardina GA, Hay DW. Sarau HM, et al. Among authors: legos jj. J Pharmacol Exp Ther. 2000 Oct;295(1):373-81. J Pharmacol Exp Ther. 2000. PMID: 10992004

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters